Pathstone Holdings
ABCL icon

Pathstone Holdings’s AbCellera Biologics ABCL Stock Holding History

Pathstone Holdings’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,811
Closed -$43.9K – 2329
2025
Q2 		$43.9K Sell
12,811
-8,052
-39% -$20K ﹤0.01% 2150
2025
Q1 		$46.5K Sell
20,863
-500
-2% -$1.43K ﹤0.01% 2180
2024
Q4 		$62.6K Sell
21,363
-10,140
-32% -$28.2K ﹤0.01% 2255
2024
Q3 		$81.9K Buy
31,503
+14,693
+87% +$40.7K ﹤0.01% 2256
2024
Q2 		$49.8K Sell
16,810
-228
-1% -$863 ﹤0.01% 2266
2024
Q1 		$77.2K Buy
17,038
+324
+2% +$1.65K ﹤0.01% 2236
2023
Q4 		$95.4K Buy
+16,714
New +$77.5K ﹤0.01% 2151

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return